The majority of leading spine and orthopedic medtech companies saw revenue gains in 2024.
Here are 10 of the largest spine and orthopedic device companies ranked by 2024 net sales, including their year-over-year percentage changes compared to 2023.
Editor’s note: This is not an exhaustive list.
1. Johnson & Johnson — orthopedic division: $9.2 billion (+2.4% YOY)
2. Stryker — orthopedic division: $9.1 billion (+8.9% YOY)
3. Medtronic — Cranial and Spinal (fiscal year 2024): $9.4 billion (+5% YOY)
4. Zimmer Biomet: $7.7 billion (+3.8% YOY)
5. Smith + Nephew — orthopedics and sports medicine: $4.1 billion (+4.7% YOY)
6. Globus Medical: $2.5 billion (+60.6% YOY)
*Merged with NuVasive on Sept. 1, 2023
7. Enovis: $2.1 billion (+23% YOY)
8. Orthofix: $799.5 (+7% YOY)
*Merged with SeaSpine on Jan. 1, 2023
9. Alphatec: $612 million (+27% YOY)
10 ZimVie: $449.7 million (-1.6% YOY)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.